Growing public scrutiny of the medical device industry and changes in political leadership in the US House suggest FDA oversight of devices could be elevated as a target for congressional oversight hearings in 2019, health-policy experts said Nov. 27.
“We have this pendulum of oversight of FDA regulation. It goes back and forth between more regulations and safety, and...